Holen Sie sich die Stockscreener-App
1.26
0.00%
0.00
Handel nachbörslich:
1.27
0.01
+0.79%
Schlusskurs vom Vortag:
$1.26
Offen:
$1.27
24-Stunden-Volumen:
211.56K
Relative Volume:
0.38
Marktkapitalisierung:
$43.85M
Einnahmen:
$2.91M
Nettoeinkommen (Verlust:
$-220.40M
KGV:
-0.3462
EPS:
-3.64
Netto-Cashflow:
$-176.15M
1W Leistung:
-1.56%
1M Leistung:
+16.67%
6M Leistung:
-16.00%
1J Leistung:
-88.43%
1-Tages-Spanne:
$1.26
$1.275
1-Wochen-Bereich:
$1.25
$1.29
52-Wochen-Spanne:
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
Firmenname
Igm Biosciences Inc
Sektor
Branche
Telefon
650-965-7873
Adresse
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Vergleichen Sie IGMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.26 | 75.84M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-01-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-10-01 | Herabstufung | Truist | Buy → Hold |
| 2024-02-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | Fortgesetzt | Jefferies | Buy |
| 2022-10-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2021-12-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2021-08-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-22 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-07-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-07-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-28 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Wedbush | Outperform |
| 2019-10-14 | Eingeleitet | Guggenheim | Buy |
| 2019-10-14 | Eingeleitet | Jefferies | Buy |
| 2019-10-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-10-14 | Eingeleitet | Stifel | Buy |
Alle ansehen
Igm Biosciences Inc Aktie (IGMS) Neueste Nachrichten
Why IGM Biosciences Inc. stock attracts strong analyst attentionFree Low Risk Picks for Daily Trading - Newser
Multi factor analysis applied to IGM Biosciences Inc.Predictable Return Plan with Entry Guidance - Newser
Key metrics from IGM Biosciences Inc.’s quarterly dataShort-Term Trade Setup with Forecast Insight - Newser
Volume spikes in IGM Biosciences Inc. stock – what they meanFree Low Risk Picks for Daily Trading - Newser
Predicting IGM Biosciences Inc. trend using moving averagesDeep Learning Stock Forecast for Investors - Newser
Mary Beth Harler Sells 14,501 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock - MarketBeat
What makes IGM Biosciences Inc. stock price move sharplyFree Accurate Technical Trend Reversal Picks - Newser
IGM Biosciences Inc. stock daily chart insightsSwing Reversal Forecast Based on Patterns - Newser
Insider Selling: IGM Biosciences, Inc. (NASDAQ:IGMS) CFO Sells 8,741 Shares of Stock - MarketBeat
Will IGM Biosciences Inc. Recover After Recent DeclineCapital Growth With Controlled Risk Picks Suggested - metal.it
Is IGM Biosciences Inc. a growth stock or a value stockCapitalize on market trends with confidence - jammulinksnews.com
How does IGM Biosciences Inc. compare to its industry peersExponential return rates - jammulinksnews.com
Custom watchlist performance reports with IGM Biosciences Inc.Free Triple Digit Return Stock Predictions - Newser
Order flow analysis tools used on IGM Biosciences Inc. Free Trade Setups With Clear Risk Limits - Newser
How strong is IGM Biosciences Inc. company’s balance sheetBuild wealth with long-term growth strategies - jammulinksnews.com
What are analysts’ price targets for IGM Biosciences Inc. in the next 12 monthsRapid capital growth - jammulinksnews.com
What is the risk reward ratio of investing in IGM Biosciences Inc. stockBuild wealth steadily with smart stock selection - jammulinksnews.com
Published on: 2025-07-28 03:57:27 - jammulinksnews.com
Is it the right time to buy IGM Biosciences Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com
Competitive Positioning of IGM Biosciences Inc.: Is It Leading or LaggingFree Stock Market Forecasting Tools - Newser
How IGM Biosciences Inc. stock performs during market volatilityStrategic High Profit Opportunities - Newser
Igm Biosciences CFO Tahir sells $11k in stock By Investing.com - Investing.com Canada
Igm Biosciences CEO Harler sells $18k in shares By Investing.com - Investing.com Canada
Igm Biosciences CBO Decker sells $5611 in stock By Investing.com - Investing.com Canada
IGM Biosciences Executives Sell Shares to Cover Tax Obligations - TradingView
What drives IGM Biosciences Inc. stock priceExceptional trading performance - PrintWeekIndia
What analysts say about IGM Biosciences Inc. stockExtraordinary earning power - PrintWeekIndia
Will IGM Biosciences Inc. stock benefit from interest rate changesHigh-profit stock alerts - jammulinksnews.com
Fierce Biotech Layoff Tracker 2025: Rocket ejects 30% of staffers; Flagship's Tessera and Generate Bio trim teams - Fierce Biotech
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus Price Target from Brokerages - MarketBeat
IGM Biosciences Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional
Is IGM Biosciences Inc. a good long term investmentRapidly growing investment returns - jammulinksnews.com
Stockholder Sues IGM Biosciences for Alleged SEC Violations (1) - Bloomberg Law News
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 5.9%Here's What Happened - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
Finanzdaten der Igm Biosciences Inc-Aktie (IGMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):